Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

A molecular link between the active component of marijuana and Alzheimer's disease pathology.
Single-use autoinjector for peginterferon-β1a treatment of relapsing-remitting multiple sclerosis: safety, tolerability and patient evaluation data from the Phase IIIb ATTAIN study.
Adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational SMART study.
Prevention and treatment of MS: studying the effects of vitamin D.
Multigate Quality Doppler Profiles and Morphological/Hemodynamic Alterations in Multiple Sclerosis Patients.
Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group.
A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis.
Glatiramer acetate and interferon-beta throughout gestation and postpartum in women with multiple sclerosis.
Stress Management and Multiple Sclerosis: A Randomized Controlled Trial.
Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis.
Therapeutic effects of novel sphingosine-1-phosphate receptor agonist W-061 in murine DSS colitis.
Synthesis and biological evaluation of new 1,2-dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for treatment of autoimmune disorders: structure-activity relationship.
Teva Announces U.S. Supreme Court Will Hear Its Appeal on COPAXONE(R) Patent
Receptos, Inc. - Current Report: United States Securities and Exchange Commission Form 8-K
Effects of murine and human bone marrow-derived mesenchymal stem cells on cuprizone induced demyelination.
Guillain-Barré syndrome: clinical profile and management.
Balance impairment in people with multiple sclerosis: Preliminary evidence for the Balance Evaluation Systems Test.
Yield of emergent neuroimaging among children presenting with a first complex febrile seizure.
Transverse myelitis -- a review of the presentation, diagnosis, and initial management.
Considering the influence of stimulation parameters on the effect of conventional and high-definition transcranial direct current stimulation.
Clinical and MRI characterization of MS patients with a pure and severe cognitive onset.
Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1.
Axonal and oligodendrocyte-localized IgM and IgG deposits in MS lesions.
Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment.
Lipocalin 2 is present in the EAE brain and is modulated by natalizumab.

Pages